Cell and Gene Manufacturing and Logistics

1. How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale 6/29/2026

   Our latest Cell & Gene Live examined how CGT developers can choose manufacturing models that support long-term commercial success by aligning biology, operations, supply chain, and scalability from the earliest stages of development.

2. Supporting Late-Stage Drug Product Development 6/29/2026

   Meet Coriolis Pharma at CPHI Worldwide in Milan to explore solutions for late-stage drug product development, manufacturing readiness, and CMC support.

3. Accelerate Efficiency By Decoupling Collection From Manufacturing 6/26/2026

   Cryopreservation eliminates rigid timelines by decoupling collection from production, providing the flexibility needed to optimize facility use and stabilize advanced therapy supply chains.

4. How Operational Efficiency Shapes Late-Phase Manufacturability 6/26/2026

   Prioritize operational efficiency over early-stage flexibility to scale advanced therapies. Standardized workflows and qualified shipping lanes reduce variability for predictable late-phase success.

5. The Next Cancer Revolution Isn't Science– It's Manufacturing 6/25/2026

   Transitioning to distributed manufacturing can reduce costs, overcome infrastructure barriers, and expand access to advanced cell therapies for oncology patients worldwide.

6. LNP-Mediated Cell Transfection In Bioreactors Across Workflows 6/24/2026

   Lipid nanoparticles are redefining immune cell engineering. Delve into new data that demonstrates the performance across multiple cell types and bioreactor systems, supporting their potential workflows.

7. Enhancing Host Cell DNA Testing With Digital PCR 6/24/2026

   Residual host cell DNA testing is evolving with digital PCR. Discover how streamlined methods improve accuracy, minimize manual steps, and support efficient biopharmaceutical manufacturing processes.

8. Optimizing Cold Chain Biomanufacturing Capacity In Brownfield Sites 6/23/2026

   Legacy facilities weren't built for today's cold chain complexity. How are CDMOs squeezing more capacity from fixed footprints without breaking what already works?

9. Revolve 16 Series Connectors 6/23/2026

   Discover how advanced dual-valve connectors enable tool-free, sterile disconnections in biopharmaceutical manufacturing, optimizing flow paths while ensuring process safety.

10. Detection Of Adventitious Viruses Using Transcriptome NGS 6/23/2026

    NGS transcriptome methods offer a sensitive, animal-free alternative for detecting viruses in cell banks. Analyzing total mRNA transcripts enables precise identification and regulatory compliance.